PureTech Health plc
PRTC$437M
Small CapNASDAQBiotechnology🇺🇸North America56 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
PRTC News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Pirfenidone
Idiopathic Pulmonary Fibrosis
LYT-300
Healthy Volunteers
LYT-200
Metastatic Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Pirfenidone | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
LYT-300 | Phase 2 | Healthy Volunteers | - | - |
LYT-200 | Phase 2 | Metastatic Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply